June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC
Jun 2, 2025, 12:04

Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC

Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared a post on X:

Deep, multi-omic analysis of adjuvant atezolizumab for ccRCC by Sumanta K. Pal and team building on prior KIM-1 studies.
One take away is KIM-1 high, Teff high has longer DFS with atezo than placebo.”

Andy Hahn highlighted new findings from Sumanta K. Pal’s team, showing that patients with high KIM-1 and Teff expression experienced longer disease-free survival when treated with atezolizumab in adjuvant clear cell renal cell carcinoma.

Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC

More posts featuring Andy Hahn.